Mediastinal lymphangioma, also known as a lymphatic malformation, is a rare benign tumor that arises from the lymphatic system, specifically within the mediastinum, which is the central compartment of the thoracic cavity.
This condition primarily affects the lymphatic organ and is situated in the chest region.
It is characterized by a proliferation of lymphatic vessels that form a mass or cystic structure, often filled with lymph fluid.
Lymphangiomas are generally congenital and may be detected in infancy or childhood, but they can also be diagnosed in adults.
Although benign, the lesion can grow and exert pressure on surrounding structures such as the lungs, heart, esophagus, and trachea, potentially leading to respiratory distress, dysphagia, or other compressive symptoms.
Detection of mediastinal lymphangioma typically involves imaging techniques such as CT scans or MRI, which are included in torso, head & torso, and whole body scans.
These scans help in visualizing the extent and nature of the lymphatic malformation, assisting in the diagnosis and planning for potential surgical intervention if necessary.
Treatment may vary depending on the size and symptoms of the lymphangioma, ranging from careful observation to surgical resection.
In some cases, sclerotherapy, a procedure that involves injecting a solution to shrink the lymphangioma, may be employed.
It is crucial for individuals with this condition to be monitored by healthcare professionals to manage any complications that arise.